Agenda and Minutes for the 194th meeting of Regional Transfusion Directors. As of this meeting, there was no definitive date when HTLV RIA testing would become available, and the importance of a test for use in blood donor screening is highlighted. Dr Lane advises that high purity heated Factor VIII would be available in the spring but that there was a 15% loss of activity after heat treatment. There is also discussion about obstacles to achieving self-sufficiency in plasma and a shortage in plasma used for anti-d production.